Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hausleiter

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Der Internist|June 6, 2013
[Rational CT imaging in cardiology]B Bischoff, J Hausleiter
Lancet (London, England)|April 9, 2004
Scimitar syndromeM Riedelp, J Hausleiter, S Martinoff
Physics in Medicine and Biology|July 20, 2007
Local organ dose conversion coefficients for angiographic examinations of coronary arteriesH Schlattl, M Zankl, J Hausleiter, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1984
Metabolism and pharmacokinetics of metaclazepam (Talis), Part III: Determination of the chemical structure of metabolites in dogs, rabbits and menF Borchers, G Achtert, H J Hausleiter, et al.
Pneumologie (Stuttgart, Germany)|February 13, 2003
[Paracardiac infiltrate or Turkish sword?]M Riedel, S Martinoff, J Hausleiter, et al.
Journal of Chromatography|August 7, 1987
Determination of revenast hydrochloride in human plasma by gas chromatography with nitrogen-selective detectionW Gielsdorf, H J Hausleiter, W Arnemann, et al.
International Journal of Cardiac Imaging|August 24, 1999
How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?S Jost, C W Nolte, M Sturm, et al.
Arzneimittel-Forschung|November 1, 1989
Transfer of metaclazepam and its metabolites into breast milkA Schotter, R Müller, C Günther, et al.
Journal of Chromatography|May 13, 1988
Determination of eproxindine hydrochloride in human plasma by capillary gas chromatographyW Dahmen, W Gielsdorf, B Jeremic, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1986
Pharmacokinetic profile of metaclazepam (Talis), a new 1.4-benzodiazepine. Influence of different dosage regimens on the pharmacokinetic profile of metaclazepam and its main metabolite under steady-state conditionsW Gielsdorf, K H Molz, H J Hausleiter, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Der Internist|June 6, 2013
[Rational CT imaging in cardiology]B Bischoff, J Hausleiter
Lancet (London, England)|April 9, 2004
Scimitar syndromeM Riedelp, J Hausleiter, S Martinoff
Physics in Medicine and Biology|July 20, 2007
Local organ dose conversion coefficients for angiographic examinations of coronary arteriesH Schlattl, M Zankl, J Hausleiter, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1984
Metabolism and pharmacokinetics of metaclazepam (Talis), Part III: Determination of the chemical structure of metabolites in dogs, rabbits and menF Borchers, G Achtert, H J Hausleiter, et al.
Pneumologie (Stuttgart, Germany)|February 13, 2003
[Paracardiac infiltrate or Turkish sword?]M Riedel, S Martinoff, J Hausleiter, et al.
Journal of Chromatography|August 7, 1987
Determination of revenast hydrochloride in human plasma by gas chromatography with nitrogen-selective detectionW Gielsdorf, H J Hausleiter, W Arnemann, et al.
International Journal of Cardiac Imaging|August 24, 1999
How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?S Jost, C W Nolte, M Sturm, et al.
Arzneimittel-Forschung|November 1, 1989
Transfer of metaclazepam and its metabolites into breast milkA Schotter, R Müller, C Günther, et al.
Journal of Chromatography|May 13, 1988
Determination of eproxindine hydrochloride in human plasma by capillary gas chromatographyW Dahmen, W Gielsdorf, B Jeremic, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1986
Pharmacokinetic profile of metaclazepam (Talis), a new 1.4-benzodiazepine. Influence of different dosage regimens on the pharmacokinetic profile of metaclazepam and its main metabolite under steady-state conditionsW Gielsdorf, K H Molz, H J Hausleiter, et al.
Pageof 5